Safety and efficacy results from the expansion phase of the first-in-human study evaluating TGFß inhibitor SAR439459 alone and combined with cemiplimab in adults with advanced solid tumors

Bibliographische Detailangaben

Hauptverfasser:	Robbrecht, Debbie, Doger, Bernard, Grob, Jean-Jacques, Bechter, Oliver Edgar, De Miguel, Maria J, Vieito, Maria, Schadendorf, Dirk, Curigliano, Giuseppe, Borbath, Ivan, Butler, Marcus O, Rodriguez-Vida, Alejo, Miller, Wilson H, Lin, Tun Tun, Masson, Nina, Pouzin, Clemence, Wang, Rui, Demers, Brigitte, Amrate, Amele, Abbadessa, Giovanni, Simonelli, Matteo
Format:	Other
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!